U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
tifcemalimab [INN]
Preferred Name English
TIFCEMALIMAB
INN  
Official Name English
Tifcemalimab [WHO-DD]
Common Name English
anti-BTLA monoclonal antibody TAB004
Common Name English
TAB-004
Code English
ICATOLIMAB
INN  
Common Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN B AND T LYMPHOCYTE ATTENUATOR (BTLA)) (HUMAN-MUS MUSCULUS MONOCLONAL JS004 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL JS004 .KAPPA.-CHAIN, DIMER
Common Name English
JS004
Code English
Code System Code Type Description
INN
11192
Created by admin on Wed Apr 02 00:08:25 GMT 2025 , Edited by admin on Wed Apr 02 00:08:25 GMT 2025
PRIMARY
SMS_ID
300000023656
Created by admin on Wed Apr 02 00:08:25 GMT 2025 , Edited by admin on Wed Apr 02 00:08:25 GMT 2025
PRIMARY
CAS
2236068-83-8
Created by admin on Wed Apr 02 00:08:25 GMT 2025 , Edited by admin on Wed Apr 02 00:08:25 GMT 2025
PRIMARY
NCI_THESAURUS
C168617
Created by admin on Wed Apr 02 00:08:25 GMT 2025 , Edited by admin on Wed Apr 02 00:08:25 GMT 2025
PRIMARY
FDA UNII
D40H7X1YZ0
Created by admin on Wed Apr 02 00:08:25 GMT 2025 , Edited by admin on Wed Apr 02 00:08:25 GMT 2025
PRIMARY
ACTIVE MOIETY
TIFCEMALIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966